John Bacon Insider Profile
4 Followers
John Bacon, former Director at Clinigen, holds 280.77K shares in Clinigen (Ticker: GB:CLIN). Most recently, John Bacon Sold 250,000 shares of Clinigen on Oct 03, 2017 for an estimated value of 2.73M .
John Bacon's Trading History
| CLINClinigen | Oct 03, 2017 | ― | Informative Sell | 2.73M | £2.60M | |||||||||||||||||||||||||||||
GB:CLIN
| ||||||||||||||||||||||||||||||||||
You May Also Like
John Bacon insider profile FAQ
What is the percentage of profitable transactions made by John Bacon?
The percentage of profitable transactions made by John Bacon is 33%.
What is the average return per transaction made by John Bacon?
The average return per transaction made by John Bacon is -7.10%.
What stocks does John Bacon hold?
John Bacon holds: GB:CLIN stocks.
What was John Bacon’s latest transaction?
John Bacon’s latest transaction was an Informative Sell of 2.73M .
What was John Bacon's most profitable transaction?
John Bacon’s most profitable transaction was an Informative Sell of GB:CLIN stock on October 3, 2017. The return on the trade was 25.70%.
What is John Bacon's role in Clinigen?
John Bacon's role in Clinigen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
